FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어
If you’re considering surgery for endometriosis, it’s important to know: we’re not yet at a place where medication alone can solve it. But there is hope. Just as medical advancements have transformed other conditions, we believe a breakthrough is coming. Until - facebook.com
If you’re considering surgery for endometriosis, it’s important to know: we’re not yet at a place where medication alone can solve it. But there is hope. Just as medical advancements …